SOPHARMA AD (9/2024) Notification from Ognian Donev in accordance with art. 19 from Regulation 596/2014 for exercising warrants on 19 February 2024
Report no 9/2024
- 20.02.2024, 11:03
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
SOPHARMA AD (8/2024) Notification for Sales revenues for January 2024
Report no 8/2024- 19.02.2024, 13:05
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (6/2024) Individual financial report according to IFRS as of 31 December 2023
Report no 6/2024- 30.01.2024, 13:35
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (5/2024) Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exer
Report no 5/2024- 26.01.2024, 14:18
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (3/2024) Sales revenues for December 2023
Report no 3/2024- 22.01.2024, 13:05
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (2/2024) Presentation of materials and Invitation for General Meeting of Warrant holders of Sopharma AD
Report no 2/2024- 19.01.2024, 13:33
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (1/2024) Merger of the subsidiary "Veta pharma" AD into "Sopharma" AD
Report no 1/2024- 15.01.2024, 16:13
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (255/2024) "Sopharma" AD starts the payment of the dividend for the 6 months of 2023 on January 22, 2024
Report no 255/2024- 10.01.2024, 13:03
- Kategoria: Biznes i finanse
- Źródło: ESPI
